Search results for "ACROBiosystems"
ACROBiosystems ACROBiosystems Human PD-L1 / B7-H1 Protein, His Tag (HPLC verified)
Recombinant Protein;1MG;Human PD-L1, His Tag (HPLC verified) (PD1-H5229) is expressed from human 293 cells (HEK293). It contains AA Phe 19 - Arg 238 (Accession # NP_054862.1 ).;This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 26.0 kDa. The protein migrates as 35-42 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.;Immobilized Human PD-L1, His Tag (HPLC verified) (Cat. No. PD1-H5229) at 1 μg/mL (100 μL/well) can bind Anti-Human PD-L1 MAb (Human IgG1) with a linear range of 0.1-3 ng/mL (QC tested).;Immobilized Human PD-L1, His Tag (HPLC verified) (Cat. No. PD1-H5229) at series of concentration on MonoRabᵀᴹ Anti-His Tag (C-term) Antibody precoated (0.1 μg/well) plate, can bind Human PD-1, Mouse IgG2a Fc Tag (HPLC-verified) (Cat. No. PD1-H5255) at 5 μg/mL (100 μL/well) with a linear range of 10-78 ng/mL (Routinely tested).;Biotinylated Human PD-1, Fc,Avitag (Cat. No. PD1-H82F1) at 1 μg/mL (5 μL/well) can bind Human PD-L1, His Ta
ACROBiosystems Recombinant Protein;Human PD-L1 / B7-H1 Protein, His Tag (HPLC-verified);HEK293;100UG;PD1,PDL1,PD-L1,CD274,B7-H1,B7H1,B7-H,B7H,PDCD1L1,PDCD1LG1
Recombinant Protein;Human PD-L1 / B7-H1 Protein, His Tag (HPLC-verified);100UG;Human PD-L1, His Tag (HPLC-verified) (PD1-H5229) is expressed from human 293 cells (HEK293). It contains AA Phe 19 - Arg 238 (Accession # NP_054862.1 ).;This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 26.0 kDa. The protein migrates as 35-42 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.;Immobilized Human PD-L1, His Tag (HPLC-verified) (Cat. No. PD1-H5229) at 1 μg/mL (100 μL/well) can bind Anti-Human PD-L1 MAb (Human IgG1) with a linear range of 0.1-3 ng/mL (QC tested).;Biotinylated Human PD-1, Fc Tag (Cat. No. PD1-H82F1) at 1 μg/mL (5 μL/well) can bind Human PD-L1, His Tag (HPLC-verified) (Cat. No. PD1-H5229) with a linear range of 0.02-0.625 μg/mL as determined in a alphaLISA homogeneous assay (Routinely tested).;Human PD-1, Fc Tag (Cat. No. PD1-H5257) captured on CM5 chip via anti-human IgG Fc antibody, can bind Human PD-L1, His Tag (HPLC-v
ACROBiosystems ACROBiosystems Anti-Adalimumab Antibodies
Antibody;1MG;IgG1/kappa;Recognizes Adalimumab specifically, no cross reactivity with other humanized antibodies.;Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Adalimumab F(ab')2.; ;Anti-Adalimumab Antibodies bridging ELISA for Anti-Drug Antibody (ADA) assay development.Immobilized adalimumab at 1 µg/mL, add increasing concentrations of Anti-Adalimumab Antibodies (Cat. No. ADB-Y19, 10% human serum) and then add biotinylated adalimumab at 5 µg/mL. Detection was performed using HRP-conjugated streptavidin with a sensitivity of 0.6 ng/mL. ;Demonstration of the specificity of Anti-Adalimumab Antibodies (Cat. No. ADB-Y19) to the adalimumab.;Anti-Adalimumab Antibodies (mouse IgG1, Cat. No. ADB-Y19) captured on CM5 chip via anti-mouse antibodies surface, can bind human adalimumab with an affinity constant of 1.36 pM.
ACROBiosystems ACROBiosystems Anti-Adalimumab Antibodies
Antibody;100UG;IgG1/kappa;Recognizes Adalimumab specifically, no cross reactivity with other humanized antibodies.;Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Adalimumab F(ab')2.; ;Anti-Adalimumab Antibodies bridging ELISA for Anti-Drug Antibody (ADA) assay development.Immobilized adalimumab at 1 µg/mL, add increasing concentrations of Anti-Adalimumab Antibodies (Cat. No. ADB-Y19, 10% human serum) and then add biotinylated adalimumab at 5 µg/mL. Detection was performed using HRP-conjugated streptavidin with a sensitivity of 0.6 ng/mL. ;Demonstration of the specificity of Anti-Adalimumab Antibodies (Cat. No. ADB-Y19) to the adalimumab.;Anti-Adalimumab Antibodies (mouse IgG1, Cat. No. ADB-Y19) captured on CM5 chip via anti-mouse antibodies surface, can bind human adalimumab with an affinity constant of 1.36 pM.
ACROBiosystems ACROBiosystems Anti-Cetuximab Antibodies
Antibody;1MG;IgG1/kappa;Recognizes Cetuximab specifically, no cross reactivity with other humanized antibodies.;Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Cetuximab F(ab')2.; ;Anti-Cetuximab Antibodies bridging ELISA for Anti-Drug Antibody (ADA) assay development. Immobilized cetuximab at 1 µg/mL, add increasing concentrations of Anti-Cetuximab Antibodies (Cat. No. CEB-Y28, 10% human serum) and then add biotinylated cetuximab at 5 µg/mL. Detection was performed using HRP-conjugated streptavidin with a sensitivity of 2.4 ng/mL. ;Demonstration of the specificity of Anti-Cetuximab Antibodies (Cat. No. CEB-Y28) to the cetuximab.;Anti-Cetuximab Antibodies (mouse IgG1, Cat. No. CEB-Y28) captured on CM5 chip via anti-mouse antibodies surface, can bind Human cetuximab with an affinity constant of 1.51 pM.
ACROBiosystems ACROBiosystems Anti-Cetuximab Antibodies
Antibody;100UG;IgG1/kappa;Recognizes Cetuximab specifically, no cross reactivity with other humanized antibodies.;Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Cetuximab F(ab')2.; ;Anti-Cetuximab Antibodies bridging ELISA for Anti-Drug Antibody (ADA) assay development. Immobilized cetuximab at 1 µg/mL, add increasing concentrations of Anti-Cetuximab Antibodies (Cat. No. CEB-Y28, 10% human serum) and then add biotinylated cetuximab at 5 µg/mL. Detection was performed using HRP-conjugated streptavidin with a sensitivity of 2.4 ng/mL. ;Demonstration of the specificity of Anti-Cetuximab Antibodies (Cat. No. CEB-Y28) to the cetuximab.;Anti-Cetuximab Antibodies (mouse IgG1, Cat. No. CEB-Y28) captured on CM5 chip via anti-mouse antibodies surface, can bind Human cetuximab with an affinity constant of 1.51 pM.
ACROBiosystems ACROBiosystems 200x DDM CHS buffer
Others;5ML;This 200x detergent solution contains 10%(w/v) DDM and 2% (w/v) CHS that is necessary for solubilization of membrane proteins. DDM, or n-Dodecyl β-D-Maltoside [CAS: 69227-93-6], is a maltoside based non-ionic detergent with a hydrophilic maltose head and a hydrophobic long chain alkyl tail. CHS, or Cholesteryl Hemisuccinate Tris Salt [CAS: 102601-49-0], is an ionizable anionic detergent that stabilizes large unilamellar vesicles. DDM/CHS micelles provide a more membrane-like environment for solubilization of membrane proteins, and help to keep structural integrity and activity. This 200x detergent solution is sterile-filtered and contains no other preservatives.
ACROBiosystems ACROBiosystems Rat TSLP Protein, His Tag
Recombinant Protein;100UG;Rat TSLP, His Tag (TSP-R52H3) is expressed from human 293 cells (HEK293). It contains AA Tyr 18 - Ser 135 (Accession # A0A0G2JUJ3-1).;This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 15.4 kDa.
ACROBiosystems ACROBiosystems Human CD72 Protein, His Tag
Recombinant Protein;1MG;Human CD72, His Tag (CD2-H52H3) is expressed from human 293 cells (HEK293). It contains AA Arg 117 - Asp 359 (Accession # P21854-1).;This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 30.0 kDa. The protein migrates as 30-35 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
ACROBiosystems ACROBiosystems Rat TSLP Protein, His Tag
Recombinant Protein;1MG;Rat TSLP, His Tag (TSP-R52H3) is expressed from human 293 cells (HEK293). It contains AA Tyr 18 - Ser 135 (Accession # A0A0G2JUJ3-1).;This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 15.4 kDa.
ACROBiosystems ACROBiosystems Human ANGPT2-coupled Magnetic Beads
Beads;2MG;The magnetic beads technology makes use of the easy and efficient collection of beads in magnetic field to facilitate antibody purification in a simple workflow of “bind-wash-elute”. In contrast to common separation techniques, this method does not require columns or centrifugation, and is therefore ideal in high-throughput applications. ;Immobilized 47μg ANGPT2 protein/1mg beads can bind Human TIE2 Protein, Fc Tag (Cat.No. TI2-H5255) with an EC50 of 3.228 μg/mL (QC tested).
ACROBiosystems ACROBiosystems Human EGF Protein, His Tag
Recombinant Protein;1MG;Human EGF, His Tag (EGF-H52H3) is expressed from human 293 cells (HEK293). It contains AA Asn 971 - Arg 1023 (Accession # P01133-1).;This protein carries a polyhistidine tag at the N-terminus. The protein has a calculated MW of 8.3 kDa. The protein migrates as 10-11 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.;Immobilized Human EGF, His Tag (Cat. No. EGF-H52H3) at 2 μg/mL (100 μL/well) can bind Human EGF R, Fc Tag (Cat. No. EGR-H5252) with a linear range of 0.2-5 ng/mL (QC tested).
ACROBiosystems ACROBiosystems Rat DLL3 Protein, His Tag
Recombinant Protein;1MG;Rat DLL3, His Tag (DL3-R52H3) is expressed from human 293 cells (HEK293). It contains AA Ala 25 - Ala 488 (Accession # O88671-1).;This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 50.3 kDa.
ACROBiosystems ACROBiosystems Cynomolgus FAP Protein, His Tag
Recombinant Protein;100UG;Cynomolgus FAP, His Tag (FAP-C52H3) is expressed from human 293 cells (HEK293). It contains AA Leu 26 - Asp 760 (Accession # XP_005573377).;This protein carries a polyhistidine tag at the N-terminus. The protein has a calculated MW of 87.0 kDa.
ACROBiosystems ACROBiosystems Human MARCO Protein, His Tag
Recombinant Protein;1MG;Human MARCO, His Tag (MAR-H5243) is expressed from human 293 cells (HEK293). It contains AA Met 79 - Val 520 (Accession # Q9UEW3-1).;This protein carries a polyhistidine tag at the N-terminus. The protein has a calculated MW of 45.9 kDa. The protein migrates as 60-65 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.